SSY Group (02005.HK) has obtained the drug production registration approval from the National Medical Products Administration for Sodium Cromoglicate Eye Drops 2% (0.3ml:6mg)

Zhito Finance APP news, SSY Group (02005.HK) announced that the group has obtained the drug production registration approval from China's National Medical Products Administration for Sodium Cromoglicate Eye Drops 2% (0.3ml:6mg), which belongs to Category 3 chemical drugs and is deemed to have passed the consistency evaluation.